This site is intended for healthcare professionals only
LoginRegister

NPPA fixes retail prices of 71 formulations including Empagliflozin, Metformin, Sitagliptin and Glimepiride

Written By : Ruchika Sharma |Medically Reviewed By : Dr. Kamal Kant Kohli   |  
NPPA fixes retail prices of 71 formulations including Empagliflozin, Metformin, Sitagliptin and Glimepiride
  • whatsapp
  • Telegram

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 71 formulations under Drugs (Prices Control) Order, 2013, including those containing Empagliflozin, Metformin, Sitagliptin, and Glimepiride.

The price fixation was based on the decision of 134th Authority meeting dated 26.6.2025.

Among the prominent anti-diabetic combinations, Empagliflozin and Metformin (12.5 mg/500 mg) tablets have been priced at Rs 18.10 per tablet, while the extended-release version with 1000 mg of Metformin and Empagliflozin 12.5mg is fixed at Rs 10.80. Another variant combining Empagliflozin 12.5 mg and Metformin 1000 mg (non-ER) is priced at Rs 19.64. The triple combination of Empagliflozin (10 mg), Sitagliptin (100 mg), and Metformin (1000 mg ER) is capped at Rs 31.60 per tablet across most manufacturers, with slight price variations depending on the company. The higher-strength variant containing Empagliflozin 25 mg is priced between Rs 23.00 and Rs 35.19.

Similarly, combinations of Sitagliptin, Glimepiride, and Metformin (50 mg/1 mg/500 mg) are priced between Rs 12.98 - Rs 12 per tablet, while those with 2 mg Glimepiride are fixed between Rs 14.00- Rs 14.66.

The companies manufacturing and marketing these diabetes drugs include Mankind Pharma, Cipla, Sun Pharma, Torrent Pharma, Lupin, Zydus Healthcare, Intas Pharma, Eris Lifesciences, Alkem Labs, Micro Labs, Exemed Pharma and Pure & Cure Healthcare.

Apart from these, NPPA also fixed retail prices for several other formulations including, Ciprofloxacin & Dexamethasone Eye/Ear Drops, Aspirin Gastro-resistant & Atorvastatin Capsules, Paracetamol bilayered sustained release tablets, Paracetamol Oral Suspension, Vitamin D3 (Cholecalciferol) Drops.

The notice stated that in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl.

No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1

Amoxycillin & Potassium clavulanate Tablets

Each Film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 875 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg

1 Tablet

M/s Medicef Pharma

/M/s Cadila Pharmaceuticals Ltd.

41.04

2

Aspirin Gastro-resistant & Atorvastatin Capsules

Each hard gelatin capsule contains: Aspirin IP 75mg (As Gastro-resistant Pellets) Atorvastatin Calcium IP Eqv. to Atorvastatin 10mg

(As Pellets)

1

Capsule

M/s Synokem Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd.

3.65

3

Budesonide, Glycopyrronium & Formoterol fumarate dihydrate inhalation

Each actuation delivers : Budesonide IP 200 mcg Glycopyrronium Bromide ph. Eur.eq. to Glycopyrronium

12.5 mcg Formoterol fumarate Dihydrate IP 6 mcg

1

Metered Dose

M/s Lupin Ltd.

6.11

4

Cefixime Oral Suspension

Each 5 ml of reconstituted suspension contains: Cefixime IP Equivalent to Cefixime Anhydrous 200 mg

1 ml

M/s Alps Communication Pvt. Ltd./

M/s Galpha Laboratories Ltd.

3.72

5

Ceftriaxone, Disodium Edetate & Sulbactum powder for solution for Infusion

Each vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 1000 mg Disodium Edetate IP 37 mg Sulbactam Sodium IP eq.

Sulbactam 500 mg

1 vial

M/s Protech Telelinks/ M/s Tyykem Pvt. Ltd.

515.57

6

Ceftriaxone, Disodium Edetate & Sulbactum powder for solution for Infusion

Each vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 2000 mg Disodium Edetate IP 74 mg Sulbactam Sodium IP eq.

Sulbactam 1000 mg

1 vial

M/s Protech Telelinks/ M/s Tyykem Pvt. Ltd.

1036.60

7

Combipack of Ceftriaxone, Disodium Edetate and Sulbactam powder for solution for Infusion

Each Combi-pack contains:

(A) Ceftriaxone, Disodium Edetate and Sulbactam powder for solution for infusion 1.5gm Each Vial Contains: Ceftriaxone sodium IP eq. to Ceftriaxone 1000mg Disodium Edetate IP 37mg Sulbactam Sodium IP Equivalent to Sulbactam 500mg

B) Sterile water for injections IP 10ml Each ampoules contains :

Water for injection IP 10ml

1 vial

M/s BDR Pharmaceuticals International Pvt. Ltd. M/s Bluecross Laboratories Pvt. Ltd.

447.00

8

Combipack of Ceftriaxone, Disodium Edetate and Sulbactam powder for solution for Infusion

Each Combi-pack contains:

(A) Ceftriaxone, Disodium Edetate and Sulbactam powder for solution for infusion 3.0 gm

Each Vial Contains:

Ceftriaxone sodium IP eq. to Ceftriaxone 2000 mg Disodium Edetate IP 74 mg Sulbactam Sodium IP Equivalent to Sulbactam 1000 mg

B) Sterile water for injections IP 20 ml Each ampoules contains :

Water for injection IP 20 ml

1 vial

M/s BDR Pharmaceuticals International Pvt. Ltd. M/s Bluecross Laboratories Pvt. Ltd.

626.00

9

Cefuroxime Axetil & Potassium Clavulanate Tablets

Each Film coated tablet contains:

Cefuroxime Axetil IP Eq. to Cefuroxime 500 mg Potassium clavulanate Diluted IP Eq. to Clavulanic Acid 125 mg

1 Tablet

M/s Hetero Labs ltd./ M/s Troikaa Pharmaceuticals Ltd.

61.84

10

Ciprofloxacin & Dexamethasone Eye

/Ear Drops

Ciprofloxacin Hydrochloride IP eq. to Ciprofloxacin 0.3% w/v

Dexamethasone IP 0.1% w/v Bezalkonium Chloride Solution IP 0.02 % w/v (Preservative)

1 ml

M/s Hanuchem Laboratories/ M/s Aristo

Laboratories Pvt. Ltd.

2.47

11

Combikit of Clarithromycin Tablets, Esomeprazole Tablets and Amoxicillin Tablets

Composition:

Each Strip Contains:

  1. Clarithromycin Tablets IP 2 Tablets

Each Film Coated Tablet Contains: Clarithromycin IP 500 mg

  1. Esomeprazole Tablets IP 2 Tablets

Each enteric coated Tablet Contains:

Esomeprazole Magnesium Trihydrate IP Equivalent to Esomeprazole 40 mg

  1. Amoxicillin Tablets USP 2 Tablets

Each Film Coated Tablet Contains:

Amoxycillin Trihydrate IP Equivalent to Amoxycillin 1000 mg

1 Tablet

M/s Malik Lifesciences Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd.

162.52

12

Empagliflozin & Metformin Hydrochloride Tablets

Each film coated tablet Contains: Empagliflozin 12.5 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Mediforce Healthcare Pvt. Ltd./ M/s Mankind Prime Labs Pvt. Ltd.

18.10

13

Empagliflozin & Metformin Hydrochloride (ER) Tablets

Each Film Coated Bilayered Tablet Contains: Empagliflozin 12.5mg Metformin Hydrochloride IP 1000mg

(As Extended release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd.

10.80

14

Empagliflozin & Metformin Hydrochloride Tablets

Each film coated tablet Contains: Empagliflozin 12.5 mg

Metformin Hydrochloride IP 1000 mg

1 Tablet

M/s Mediforce Healthcare Pvt. Ltd./ M/s Mankind Prime Labs Pvt. Ltd.

19.64

15

Empagliflozin, Linagliptin & Metformin (ER) Tablets

Each film coated tablet contains: Empagliflozin 10 mg,

Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (As Extended release)

1 Tablet

M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.

16.97

16

Empagliflozin, Linagliptin & Metformin (ER) Tablets

Each film coated tablet contains: Empagliflozin 25 mg,

Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (As Extended release)

1 Tablet

M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.

20.54

17

Sitagliptin, Glimepiride & Metformin Hydrochloride tablets

Each Film Coated Tablet Contains:

Glimepiride IP 1 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 50 mg Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Torrent Pharmaceuticals Ltd.

12.98

18

Sitagliptin, Glimepiride & Metformin Hydrochloride tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Micro Labs Ltd.

12.00

19

Sitagliptin, Glimepiride & Metformin Hydrochloride tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Intas Pharmaceuticals Ltd.

12.98

20

Sitagliptin, Glimepiride &Metformin Hydrochloride Tablets

Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg,

Glimepiride IP 1 mg, Metformin Hydrochloride IP 500mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Eris Lifesciences Ltd.

12.98

21

Sitagliptin, Glimepiride &Metformin Hydrochloride Tablets

Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg,

Glimepiride IP 1 mg, Metformin Hydrochloride IP 500mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Lupin Ltd.

12.98

22

Sitagliptin, Glimepiride and Metformin Hydrochloride Tablets

Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Mankind Pharma Ltd.

12.98

23

Sitagliptin, Glimepiride & Metformin Hydrochloride tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Torrent Pharmaceuticals Ltd.

14.66

24

Sitagliptin, Glimepiride & Metformin Hydrochloride tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Micro Labs Ltd.

14.00

25

Sitagliptin, Glimepiride & Metformin Hydrochloride tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Intas Pharmaceuticals Ltd.

14.66

26

Sitagliptin, Glimepiride &Metformin Hydrochloride Tablets

Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg,

Glimepiride IP 2 mg, Metformin Hydrochloride IP 500mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Lupin Ltd.

14.66

27

Sitagliptin,Glimepiride &Metformin Hydrochloride Tablets

Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Mankind Pharma Ltd.

14.66

28

Itraconazole Capsules (Supra- Bioavailable formulation)

Each hard gelatin capsule contains: Itraconazole IP 65 mg

1

Capsule

M/s Ravenbhel Healthcare Pvt. Ltd/ M/s Intas Pharmaceuticals Ltd.

11.45

29

Levofloxacin Infusion

Each 100 ml contains: Levofloxacin Hemihydrate IP eq. to Levofloxacin 500 mg Dextrose (Anhydrous) IP 5% w/v

1 ml

M/s Axa Parenterals Ltd./

M/s Aristo Laboratories Pvt. Ltd.

1.46

30

Linezolid injection

Each 100ml contains: Linezolid IP 200 mg, Dextrose Anhydrous IP 5% w/v

1 ml

M/s Amanta Healthcare Ltd. / M/s Corona Remedies Pvt. Ltd.

1.60

31

Methylprednisolone Tablets

Each uncoated tablet contains: Methylprednisolone IP 8 mg

1 Tablet

M/s Innova Captab Ltd.

/ M/s Troikaa Pharmaceuticals Ltd.

5.22

32

Moxifloxacin Eye Drops

Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5% w/v

Benzalkonium Chloride Solution IP 0.02% v/v (as

preservative) Sterile aqueous buffered vehicle

1 ml

M/s Hanuchem Laboratories / M/s Aristo Laboratories Pvt. Ltd.

36.26

33

Myo-Inositol,D-Chiro Inositol &Vitamin D3 Powder

Each 5g Sachet contains: Vitamin D3 (Stabilized form) 1000 IU,

Myo-Inositol IP 2000 mg, D-Chiro Inositol 50 mg

1 gm

M/s Safetab Life Science/

M/s Corona Remedies Pvt. Ltd.

9.02

34

Paracetamol bilayered sustained release tablets

Each uncoated bilayered sustained release tablet contains:

Paracetamol IP (as Immediate release ) 300 mg

Paracetamol IP (as sustained release) 700 mg

1 Tablet

M/s Pure and cure Healthcare Pvt. Ltd./ M/s Glaxosmithkline Asia Pvt. Ltd.

4.71

35

Paracetamol Oral Suspension

Each 5 ml Contains: Paracetamol IP 500 mg

1 ml

M/s Naxpar Pharma Pvt. Ltd./

M/s Micro Labs Ltd.

0.66

36

Paracetamol Oral Suspension

Each 5ml contains: Paracetamol IP 500mg

1 ml

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd.

0.66

37

Ibuprofen & Paracetamol suspension

Each 5 ml contains: Ibuprofen IP 100 mg Paracetamol IP 162.5 mg

1 ml

M/s Mascot Health Series Pvt. Ltd./ M/s Alembic

Pharmaceuticals Ltd.

0.53

38

Mefenamic Acid & Paracetamol suspension

Each 5 ml contains: Mefenamic Acid IP 100 mg Paracetamol IP 250 mg

1 ml

M/s Mascot Health Series Pvt. Ltd./ M/s Alembic

Pharmaceuticals Ltd.

0.94

39

Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Tablets

Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 10 mg

Chlorpheniramine Maleate IP 2 mg

1 Tablet

M/s East African (India) Overseas / M/s Aristo Laboratories Pvt. Ltd.

5.25

40

Polmacoxib & Paracetamol Tablets

Each uncoated tablet contains: Polmacoxib IH 2 mg, Paracetamol IP 325 mg

1 Tablet

M/s Hetero Labs Ltd. / M/s Intas Pharmaceuticals Ltd.

15.39

41

Aceclofenac, Paracetamol & Trypsin Chymotrypsin Tablets

Each enteric coated tablet contains:

Proteolytic enzymes Trypsin & Chymotrypsin in the ratio of Approximately 6:1 and provides enzymatic activity Eq. to

1,50,000 Armour units Aceclofenac IP 100 mg Paracetamol IP 325 mg

1 Tablet

M/s Akums Drugs & pharmaceuticals Ltd / M/s Aristo Pharmaceutical Pvt. Ltd

15.18

42

Trastuzumab for Injection

Each Lyophilized vial contains:

Trastuzumab (In House) (375 mg) - α, α Trehalose dihydrate Ph. Eur. (340.91 mg) - L-

Histidine HCl monohydrate Ph. Eur. (8.44 mg) -L-

Histidine Ph. Eur. (5.45 mg) - Polysorbate 20 IP (1.53 mg)

1 vial

M/s Reliance Life Sciences Pvt. Ltd.

11966.64

43

Vitamin D3 (Cholecalciferol) Drops

Each ml contains: Cholecalciferol (Vitamin D3) IP 800 IU

1 ml

M/s Indchemie Health Specialities Pvt. Ltd.

6.11

44

Zolpidem Tartrate & Melatonin tablets

Each film coated tablet contains:

Zolpidem Tartrate IP 5 mg Melatonin BP 3 mg

1 Tablet

M/s Windlas Biotech Ltd./

M/s Intas Pharmaceuticals Ltd.

6.62

45

Phenylephrine HCl, Chlorpheniramine Maleate, Boric Acid & Hydroxypropylmethyl Cellulose Eye Drops

Composition: Phenylephrine HCl IP 0.12

%w/v

Chlorpheniramine Maleate IP

0.2 % w/v

Boric Acid IP 1.25 % w/v Hydroxypropylmethyl Cellulose IP 0.3 % w/v Benzalkonium Choride IP 0.01

% w/v

1 ml

M/s Appasamy Ocular Devices Pvt. Ltd./ M/s Intas Pharmaceuticals Ltd.

7.63

46

Methylcobalamin , Alpha Lipoic Acid, Pyridoxine Hydrochloride & Folic Acid Capsules

Each hard gelatin capsule contains :

Methylcobalamin IP 1500 mcg Alpha Lipoic Acid IP 100 mg Pyridoxine Hydrochloride IP 3 mg

Folic Acid IP 1.5mg

1

Capsule

M/s East African (India) Overseas/ M/s Softdeal Pharmaceutical Pvt. Ltd.

14.64

47

Zolpidem Tartrate & Melatonin tablets

Each film coated tablet contains:

Zolpidem Tartrate IP 10 mg Melatonin BP 3 mg

1 Tablet

M/s Windlas Biotech Ltd./

M/s Intas Pharmaceuticals Ltd.

9.02

48

Myo-Inositol, D-Chiro Inositol & Vitamin D3 powder

Each 5g Sachet contains: Vitamin D3 IP (Water soluble) 1000 IU

Myo-Inositol IP 2000 mg D-Chiro Inositol 50 mg

1 gm

M/s Safetab Life Science / M/s Sun Pharma Laboratories Limited

9.02

49

Metoprolol succinate (ER), Amlodipine & Telmisartan Tablets

Each film coated bilayered tablet contains:

Metoprolol Succinate IP 23.75 mg eq. to Metoprolol Tartrate 25 mg (As extended release) Amlodipine Besilate IP eq. to Amlodipine 5 mg

Telmisartan IP 40 mg

1 Tablet

M/s Ajanta Pharma Ltd.

12.96

50

Dehydroepiandrosterone (DHEA)(Micronised) & Folic Acid Capsules

Each hard gelatin capsule contains: Dehydroepiandrosterone (DHEA)(Micronised) 25 mg, Folic Acid IP 1.5 mg

1

Capsule

M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Sun Pharma Laboratories Ltd.

14.08

51

Glycopyrronium & Formoterol Fumarate inhaler

Each actuation delivers: Glycopyrronium (As Glycopyrrolate IP) 12.5mcg Formoterol Fumarate Dihydrate IP 6mcg

1

meterede dose

M/s Cipla Ltd.

4.08

52

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 10 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Corona Remedies Pvt. Ltd.

31.60

53

Empagliflozin, Sitagliptin & Metformin (ER) tablets

Each Film Coated Bilayer Tablet contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100 mg Metformin Hydrochloride IP (As Extended Release) 1000 mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited

31.60

54

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to

Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Alkem Laboratories Ltd.

31.60

55

Empagliflozin

,Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 10mg Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As extended release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Lupin Ltd

25.00

56

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Torrent Pharmaceuticals Ltd.

22.50

57

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Mankind Pharma Ltd.

31.60

58

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.

25.00

59

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 10 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Ltd.

31.60

60

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 10 mg,

Sitagliptin Phosphate

Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Cipla Ltd.

22.00

61

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Sun Pharmaceuticals Industries Ltd.

26.00

62

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 25 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Cipla Ltd.

23.00

63

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 25 mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Ltd.

35.19

64

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 25mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Mankind Pharma Ltd.

35.19

65

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Torrent Pharmaceuticals Ltd.

25.00

66

Empagliflozin,

Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer

Tablet Contains:

Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed

Pharmaceuticals / M/s Sun Pharmaceuticals Industries Ltd.

30.00

67

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.

26.00

68

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each Film Coated bilayer Tablet Contains: Empagliflozin 25mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As Extended Release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Alkem Laboratories Ltd.

34.00

69

Empagliflozin

,Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100mg Metformin Hydrochloride IP (As extended release) 1000mg

1 Tablet

M/s Exemed Pharmaceuticals / M/s Lupin Ltd

30.00

70

Empagliflozin, Sitagliptin & Metformin (ER) tablets

Each Film Coated Bilayer Tablet contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP Equivalent to Sitagliptin 100 mg Metformin Hydrochloride IP (As Extended Release) 1000 mg.

1 Tablet

M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited

35.19

71

Empagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 25mg, Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100mg, Metformin Hydrochloride IP 1000mg (as extended release)

1 Tablet

M/s Exemed Pharmaceuticals / M/s Corona Remedies Pvt. Ltd.

35.19

Note:

(a) The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

For more details, check out official notice:

https://medicaldialogues.in/pdf_upload/b84c87bfcc4e6d6788482ab161474c08-293835.pdf


NPPAEmpagliflozinMetforminSitagliptinGlimepirideparacetamolmankind pharmaciplasun pharmatorrent pharmalupinzydus healthcareintas pharmaeris lifesciencesalkem labsmicro labsexemed pharmanational pharmaceutical pricing authority
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story
    X